Developing a Cost-Effective Genomic Biomarker of Cancer Risk in Patients with Ulcerative Colitis using Low-Pass Whole Genome Sequencing of Unselected Endoscopic Biopsies: A Case-Control Study

被引:1
|
作者
Al Bakir, I. [1 ]
Curtius, K. [1 ]
Smith, K. [1 ]
Kopczynska, M. [1 ]
Moorghen, M. [2 ]
Hart, A. [3 ]
Graham, T. [1 ]
机构
[1] Queen Mary Univ London, Barts Canc Inst, London, England
[2] St Marks Hosp, Dept Pathol, Harrow, Middx, England
[3] St Marks Hosp, Dept Gastroenterol, Harrow, Middx, England
来源
关键词
D O I
10.1093/ecco-jcc/jjab075.037
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OP38
引用
收藏
页码:S035 / S036
页数:3
相关论文
共 2 条
  • [1] DEVELOPING A GENOMIC BIOMARKER OF CANCER RISK IN PATIENTS WITH UC USING UNSELECTED ENDOSCOPIC BIOPSIES
    Al Bakir, Ibrahim
    Curtius, Kathleen
    Smith, Kane
    Kopczynska, Maja
    Moorghen, Morgan
    Hart, Ailsa
    Graham, Trevor
    GUT, 2021, 70 : A6 - A7
  • [2] Epigenome-wide association study for breast cancer risk using whole genome and target captured bisulphite sequencing: A pooled case-control study nested in the breakthrough generations study
    Flanagan, J. M.
    Curry, E.
    Stirling, L.
    Flower, K.
    Orr, N.
    Tomczyk, K.
    Coulson, P.
    Jones, M.
    Ashworth, A.
    Swerdlow, A.
    Brown, R.
    Garcia-Closas, M.
    CANCER RESEARCH, 2017, 77